Jack Slevin
Stock Analyst at Jefferies
(1.48)
# 3,548
Out of 5,150 analysts
5
Total ratings
40%
Success rate
1.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Slevin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Maintains: Buy | $44 → $37 | $25.59 | +44.59% | 1 | Nov 25, 2025 | |
| AGL agilon health | Maintains: Hold | $2.4 → $1.1 | $0.70 | +57.48% | 1 | Aug 15, 2025 | |
| MD Pediatrix Medical Group | Maintains: Buy | $14 → $18 | $19.88 | -9.46% | 2 | Nov 5, 2024 | |
| TOI The Oncology Institute | Assumes: Buy | $2.5 | $2.85 | -12.28% | 1 | Feb 26, 2024 |
Astrana Health
Nov 25, 2025
Maintains: Buy
Price Target: $44 → $37
Current: $25.59
Upside: +44.59%
agilon health
Aug 15, 2025
Maintains: Hold
Price Target: $2.4 → $1.1
Current: $0.70
Upside: +57.48%
Pediatrix Medical Group
Nov 5, 2024
Maintains: Buy
Price Target: $14 → $18
Current: $19.88
Upside: -9.46%
The Oncology Institute
Feb 26, 2024
Assumes: Buy
Price Target: $2.5
Current: $2.85
Upside: -12.28%